Table 2– Significant results (p<0.05) from linear regression analysis of pulmonary function tests and computed tomography-scan data with mRNA expression at baseline
GeneOutcomer2p-value
MMP1Semiquantitative score for emphysema0.05970.0052
MMP12FEV1 % pred0.25650.0265
FEV1/FVC %0.23938×10−5
DLCO/VA % pred0.21120.0004
TIMP2FEV1 % pred0.25470.0299
CST3FEV1 % pred0.27360.0087
  • MMP: metalloproteinase; TIMP: tissue inhibitors of metalloproteinase; CST3: cystatin C; FEV1: forced expiratory volume in 1 s; % pred: % predicted; FVC: forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; VA: alveolar volume. Coefficients of determination (r2) and p-values were calculated from regression analysis of each clinical outcome including age, sex, race, pack-years and mRNA expression as covariates. r2 values are for the whole model, p-values are for the mRNA expression level. FEV1 % pred and FEV1/FVC % were measured post-bronchodilator. An ordinal logistic regression was performed for the semiquantitative emphysema scores. DLCO/VA % pred was log-transformed. Significant results after correction for multiple comparisons are shown in bold. The p-value threshold is 0.05/(9×4.45)=0.0012. Complete results are shown in online supplementary table S7.